Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: Results of the prospective German brain tumor trials HIT-SKK 87 and 92-Reference-Cited by-同舟云学术

Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: Results of the prospective German brain tumor trials HIT-SKK 87 and 92

Published:2005-12 Issue:3 Volume:77 Page:278-285
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Timmermann Beate,Kortmann Rolf-Dieter,Kühl Joachim,Rutkowski Stefan,Dieckmann Karin,Meisner Christof,Bamberg Michael

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference49 articles.

1. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children;Ater;J Neurooncol,1997

2. Non-metastatic childhood ependymomas;Carrie;Radiother Oncol,1995

3. Intracranial ependymoma in children: analysis of prognostic factors;Chiu;J Neurooncol,1992

4. Postoperative irradiation of brain ependymomas. Analysis of 33 cases;Di Marco;Acta Oncol,1988

5. Treatment of brain tumors in babies and very young children;Duffner;Pediatr Neurosci,1985

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ependymoma from Benign to Highly Aggressive Diseases: A Review;Advances and Technical Standards in Neurosurgery;2024

2. Preoperative MR - based model for predicting prognosis in patients with intracranial extraventricular ependymoma;2023-11-14

3. Treatments associated with all-cause mortality among children with primary brain and central nervous system tumors: a retrospective cohort study from the SEER database;Translational Pediatrics;2023-08

4. Kinder und Jugendliche mit intrakraniellem Ependymom – Empfehlungen der HIT-MED-Studiengruppe der GPOH zur Erstlinientherapie;Klinische Pädiatrie;2023-05

5. Congenital medulloblastoma in two brothers with SUFU-mutated Gorlin-Goltz syndrome: Case reports and literature review;Frontiers in Oncology;2022-10-12